Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions
This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
Hepatocellular Carcinoma: Examining the Latest Evidence for Managed Care
This supplement was developed with the goal of providing pharmacists and managed care professionals with an understanding of current treatment options for HCC, with a focus on assisting managed care professionals in optimizing patient outcomes.
Establishing Clinical Pathways for the Management of Advanced/Metastatic Renal Cell Carcinoma: A Focus on New and Emerging First-Line Treatment Strategies
This virtual symposium will help managed care pharmacists better delineate current and emerging treatment strategies for advanced/metastatic ccRCC.
Current and Emerging Treatment Options for Chronic Cough: The Role of Managed Care
This activity will construct a treatment plan for patients with chronic cough that targets the type of cough and minimizes adverse effects.